Achilles Therapeutics Announces $12M AstraZeneca Deal, Plans Job Cuts

Benzinga00:56

Express News | Achilles: Proprietary data, TRACERx samples, and material acquisition platforms will be transferred to AstraZeneca.

BreakingsDec 24 22:37

Achilles Therapeutics Sells TRACERx And MAP Assets To AstraZeneca For $12M, Transferring Tumor Data And Samples; Concludes Strategic Review With Plans For Workforce And Board Reductions

BenzingaDec 24 22:31

Press Release: Achilles Therapeutics Announces Sale of Technology Assets to AstraZeneca

Dow JonesDec 24 22:30

London Shares Festive Ahead of Christmas Break; Vistry Slumps on Fresh Profit Warning

MT NewswiresDec 24 20:48

AstraZeneca, Daiichi Sankyo Withdraw EU Marketing Application for Lung Cancer Drug Candidate

MT NewswiresDec 24 18:59